Is maternal thyrotropin releasing hormone administration safe in the pregnant woman with preeclampsia?

Ann S.A. Tan, Chaur Dong Hsu, Sara Marder, Joshua A. Copel

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Maternal intravenous administration of thyrotropin releasing hormone (TRH) is associated with rapid elevations of blood pressure, potentially causative of cerebrovascular accidents. We report a case in which peak blood pressure of 220/120 mm Hg was attained from a baseline of 132/80 mm Hg following TRH administration in a preeclamptic patient.

Original languageEnglish (US)
Pages (from-to)5-6
Number of pages2
JournalAmerican Journal of Perinatology
Volume14
Issue number1
DOIs
StatePublished - Jan 1997
Externally publishedYes

Keywords

  • Preeclampsia
  • blood pressure
  • thyrotropin releasing hormone (TRH)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Is maternal thyrotropin releasing hormone administration safe in the pregnant woman with preeclampsia?'. Together they form a unique fingerprint.

Cite this